Lacto-N-Neotetraose LNnT supplementation for targeted health support.
Human Milk Oligosaccharide. Complex sugars in breast milk that feed infant gut bacteria. Now producible through fermentation for supplements.
Originally studied in infants. Now being researched for adult gut health. The mechanism (feeding Bifidobacteria) works at any age.
More selective. HMOs specifically promote Bifidobacteria. Regular prebiotics like inulin feed many bacteria types, including some you might not want.
Click through to the studies bar for the evidence base.
See the dosing guide below.
Compare formats before buying.
Some ingredients build up over weeks. Others act fast.
The compound effect of consistent dosing.
Check the cautions section if you have a pre-existing condition.
Some ingredients you feel. Others just work in the background.
Complex fermentation process to produce HMOs identical to those in breast milk. Production is expensive compared to plant-derived prebiotics.
Only significant source is human breast milk. Cow's milk has trace amounts of different oligosaccharides. Supplements fill the gap.
Makes sense. The LNnT feeds Bifidobacteria. Taking Bifido probiotics while providing their preferred food is synergistic.
Most research uses 5.0g daily. Below 1.5g, you're probably wasting money. Above 8.0g, no extra benefit. The curve plateaus. Safe upper limit ~ 10.0g.
Lacto-N-Neotetraose LNnT has emerging evidence.
Found naturally in human breast milk
Lacto-N-Neotetraose LNnT interacts with other supplements and meds. The analyzer flags interactions, dose mismatches, and timing collisions across your whole list.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.